Nuclear Radiology: Page 81

PET/CT improves preoperative staging of non-small cell lung cancer
By Reuters Health
NEW YORK (Reuters Health), Jul 2 - Combined positron-emission tomography and computed tomography (PET/CT) improves the staging of non-small cell lung cancer and also reduces the numbers of total and futile thoracotomies, Danish researchers report in the July 2 New England Journal of Medicine.
July 1, 2009
Reuterslogo
FDG-PET/CT predicts radiation-induced lung toxicity
By AuntMinnieEurope.com staff writers
FDG-PET/CT exams may be able to identify lung cancer patients who are highly susceptible to developing radiation-induced lung toxicity early during radiation therapy, according to researchers at the Maastricht University Medical Center in the Netherlands.
June 30, 2009
New way to correct data distortions benefits PET/MR
By AuntMinnieEurope.com staff writers
Researchers from Philips Healthcare offered new details on the company's development of a hybrid PET/MRI scanner at this week's annual SNM meeting in Toronto.
June 18, 2009
New form of radiotherapy for prostate cancer works in mice
By Reuters Health
NEW YORK (Reuters Health), Jun 18 - The alpha particle-emitting radiopeptide 213 Bi-DOTA-PESIN is effective for treating prostate cancer in mice, according to research presented at the SNM's annual meeting in Toronto this week.
June 17, 2009
Reuterslogo
Images may look different on sitting gamma cameras
By AuntMinnieEurope.com staff writers
TORONTO - Cardiac images produced on gamma cameras in which patients are imaged in the sitting position may look different than those from standard supine-oriented gamma cameras, a phenomenon that clinicians should be aware of, according to a presentation at this week's SNM meeting.
June 16, 2009
Society of Nuclear Medicine issues Medical Isotope Communiqué
By Reuters Health
NEW YORK (Reuters Health), Jun 16 - Monday, the Society of Nuclear Medicine (SNM), together in partnership with a variety of key stake holders, issued a Medical Isotope Communiqué, with the goal of solving the medical isotope crisis.
June 15, 2009
Reuterslogo
Canada cites dangers in abandoned isotope reactors as major reactor remains down
By Reuters Health
OTTAWA (Reuters), Jun 16 - One of the reasons Canada abandoned a project last year to build new reactors to produce medical isotopes was the risk they could not be shut down if something went wrong, Natural Resources Minister Lisa Raitt said on Friday.
June 15, 2009
Reuterslogo
SNM study: Radiopeptides for prostate cancer look promising
By AuntMinnieEurope.com staff writers
A potential new weapon in the arsenal for treating prostate cancer is being discussed at this week's SNM annual meeting in Toronto.
June 14, 2009
MDS, Karpov Institute to study Mo-99 supply
By AuntMinnieEurope.com staff writers
MDS Nordion and the Karpov Institute of Physical Chemistry have agreed to study the feasibility of the institute providing the firm with a supply of molybdenum-99 (Mo-99) for the global nuclear medicine market.
June 14, 2009
Facing Mo-99 shortage, nuclear medicine economizes
By Alexandra Weber Morales
What would a world without molybdenum-99 (Mo-99) look like? That's a question U.S. nuclear medicine physicians are contemplating as limited Mo-99 supplies decay by half every 66 hours.
June 10, 2009
2009 01 27 15 41 57 86 Nuclear Reactor 70
Aposense teams with GlaxoSmithKline
By AuntMinnieEurope.com staff writers
Molecular imaging and therapy developer Aposense is collaborating with pharmaceutical firm GlaxoSmithKline to evaluate the potential of Aposense's ML-10 PET tracer in monitoring drug activity in clinical studies of cancer therapies.
June 7, 2009
IBA inks pact with BV Cyclotron
By AuntMinnieEurope.com staff writers
Ion Beam Applications (IBA) and BV Cyclotron will collaborate on the production and distribution of fluorine-18-labeled radiopharmaceuticals used in PET imaging.
May 31, 2009
Previous Page
Page 81 of 90
Next Page